Conference
Evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.
Authors
Barron C; Kaur U; Mustafa Al-Hussein M; Brown M; Cosman T; Mukherjee S; Ellis PM; Dhesy-Thind SK; Leong D
Volume
36
Pagination
pp. e18548-e18548
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.e18548
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X